Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor.

[1]  C. Wahlestedt,et al.  Small GTP-Binding Protein Rac Is an Essential Mediator of Vascular Endothelial Growth Factor-Induced Endothelial Fenestrations and Vascular Permeability , 2003, Circulation.

[2]  Dawn M. Nekorchuk,et al.  Bartonella-associated endothelial proliferation depends on inhibition of apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Takayuki Asahara,et al.  The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors , 2001, Nature Medicine.

[4]  J. Mulliken,et al.  Clonality and altered behavior of endothelial cells from hemangiomas. , 2001, The Journal of clinical investigation.

[5]  G. Davis,et al.  Formation of stress fibres in human endothelial cells infected with Bartonella bacilliformis is associated with altered morphology, impaired migration and defects in cell morphogenesis , 2001, Cellular microbiology.

[6]  J. Arbiser,et al.  Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy. , 2001, Journal of the American Academy of Dermatology.

[7]  I. Stamenkovic,et al.  Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. , 2001, The American journal of pathology.

[8]  D. Wiederschain,et al.  Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. , 2000, The American journal of pathology.

[9]  G. Davis,et al.  Infection of Human Endothelial Cells with Bartonella bacilliformis Is Dependent on Rho and Results in Activation of Rho , 2000, Infection and Immunity.

[10]  D. Mukhopadhyay,et al.  Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner , 2000, Oncogene.

[11]  Ji-Hye Kim,et al.  Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway , 2000, Oncogene.

[12]  J. Mulliken,et al.  VEGF and its receptors are expressed in a pediatric angiosarcoma in a patient with Aicardi's syndrome. , 2000, The Journal of investigative dermatology.

[13]  R. Amirnovin,et al.  Vascular Apoptosis and Involution in Gliomas Precede Neovascularization: A Novel Concept for Glioma Growth and Angiogenesis , 2000, Laboratory Investigation.

[14]  H. Dvorak,et al.  Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. , 2000, The American journal of pathology.

[15]  S. Soker,et al.  Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. , 2000, The American journal of pathology.

[16]  N. Ahn,et al.  Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. , 2000, Cancer Research.

[17]  G. Yancopoulos,et al.  In Situ Expression of Angiopoietins in Astrocytomas Identifies Angiopoietin-2 as an Early Marker of Tumor Angiogenesis , 1999, Experimental Neurology.

[18]  C. Bucana,et al.  Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. , 1999, International journal of oncology.

[19]  M. Makuuchi,et al.  Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. , 1999, The Journal of clinical investigation.

[20]  S. Rafii,et al.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.

[21]  D. Spach,et al.  Bartonella-associated infections. , 1998, Infectious disease clinics of North America.

[22]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[23]  R. D'Amato,et al.  Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 , 1997, Nature Medicine.

[24]  J. Folkman,et al.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Detmar,et al.  Murine psoriasis-like disorder induced by naive CD4+ T cells , 1997, Nature Medicine.

[26]  D. Hanahan,et al.  Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. , 1996, Oncogene.

[27]  C. Ballaun,et al.  Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[28]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[29]  H. Dvorak,et al.  Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. , 1996, The American journal of pathology.

[30]  J. Arbiser.  Angiogenesis and the skin: a primer. , 1996, Journal of the American Academy of Dermatology.

[31]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Mulliken,et al.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood. , 1994, The Journal of clinical investigation.

[33]  H. Pass,et al.  Simian virus 40-like DNA sequences in human pleural mesothelioma. , 1994, Oncogene.

[34]  S. Jabłońska,et al.  Synergistic effect of retinoids and interferon α on tumor‐induced angiogenesis: Anti‐angiogenic effect on HPV‐harboring tumor‐cell lines , 1994, International journal of cancer.

[35]  J. Tappero,et al.  Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. , 1992, The New England journal of medicine.

[36]  J. Wojta,et al.  Interactions between live Bartonella bacilliformis and endothelial cells. , 1992, The Journal of infectious diseases.

[37]  J. Wojta,et al.  Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. , 1990, The American journal of pathology.

[38]  J. Sutton.  DANIEL CARRION AND OROYA FEVER , 1971, Medical Journal of Australia.

[39]  B. Zhong,et al.  Regulation of Akt-dependent cell survival by Syk and Rac. , 2003, Blood.

[40]  M. Mihm,et al.  GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. , 2000, Human pathology.

[41]  E. Manseau,et al.  Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. , 1996, Cancer research.

[42]  R. Patarca,et al.  Verruga peruana: an infectious endemic angiomatosis. , 1995, Critical reviews in oncogenesis.

[43]  J. Folkman.  Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.